Exelixis to Merge with X-Ceptor Therapeutics
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 53 (Table of Contents)
Published: 4 Nov-2004
DOI: 10.3833/pdr.v2004.i53.765 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Exelixis entered into an agreement to acquire X-Ceptor Therapeutics, thereby substantially expanding its product portfolio with small molecules that modulate nuclear hormone receptors (NHRs)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS